Pfizer Dividends payable decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Over 5 years (FY 2020 to FY 2025), Dividends payable shows an upward trend with a 2.5% CAGR.
A consistent or growing balance reflects a stable dividend policy and commitment to shareholder returns.
Dividends payable represents the amount of cash dividends declared by the board of directors that have not yet been dist...
Standard for mature, dividend-paying companies in the pharmaceutical sector.
dividends_payable| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.18B | $2.19B | $2.25B | $0.00 | $2.25B | $2.25B | $2.30B | $0.00 | $2.32B | $0.00 | $2.37B | $0.00 | $2.38B | $0.00 | $2.44B | $0.00 | $2.45B | $0.00 | $2.45B | $0.00 |
| QoQ Change | — | +0.3% | +2.6% | -100.0% | — | +0.0% | +2.6% | -100.0% | — | -100.0% | — | -100.0% | — | -100.0% | — | -100.0% | — | -100.0% | — | -100.0% |
| YoY Change | — | — | — | — | +2.8% | +2.5% | +2.4% | — | +3.1% | -100.0% | +3.0% | — | +2.8% | — | +2.7% | — | +2.7% | — | +0.3% | — |